Get started
Author

Megumi Mizutani

Observed name: Mizutani, Megumi
ORCID: 0009-0009-4354-2620
Observed ORCID: 0009-0009-4354-2620
OpenAlex ID: A5049043100
Derived neutrophil-to-lymphocyte ratio has the potential to predict safety and outcomes of durvalumab after chemoradiation in non-small cell lung cancer
2024 · Akira Sugimoto, Hiroyasu Kaneda, et al. · Scientific Reports · 13
PDF
Risk Factors for Lower Adherence to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study in Japan
2025 · Yasutaka Ihara, Shoichiro Yamamoto, et al. · Oncology · 5
A Retrospective Study of the Utility of the Oncomine™ Dx Target Test in Clinical Practice
2022 · Shinya Uematsu, Megumi Mizutani, et al. · Haigan · 4
PDF
Risk Factors for Venous Thromboembolism in Advanced Non-Small Cell Lung Cancer ― A Nationwide Administrative Database Study ―
2026 · Tetsuya Kimura, Yugo Yamashita, et al. · Circulation Reports · 3
PDF
Immunotherapy Following Anaplastic Lymphoma Kinase Inhibitor Therapy for Patients with Anaplastic Lymphoma Kinase‑Positive Non‑small Cell Lung Cancer in Japan
2024 · Yuki Shimomura, Megumi Mizutani, et al. · Targeted Oncology · 3
Insulin-like growth factor 1 receptor expression correlates with programmed death ligand 1 expression and poor survival in non-small cell lung cancer
2024 · Hiroaki Nagamine, Masakazu Yashiro, et al. · PLoS ONE · 3
PDF
Pseudoprogression of pleural effusion in lung cancer treated with immunotherapy: a case report
2025 · Hiroyasu Kaneda, Lan Wang, et al. · Translational Lung Cancer Research · 2
Impact of immunotherapy on survival and treatment patterns of patients with extensive-stage small cell lung cancer: a study using a Japanese nationwide database
2026 · Yasutaka Ihara, Shoichiro Yamamoto, et al. · Future Oncology · 1
A Case of ALK-rearranged Lung Cancer with a Durable Response to Atezolizumab Plus Bevacizumab/Carboplatin/Paclitaxel Combination Therapy After Initial Resistance to Alectinib
2023 · Megumi Mizutani, Hwang Moon Hee, et al. · Haigan · 1
PDF
The Impact of Tumor Immune Microenvironment in EGFR-Mutant Non-Small Cell Lung Cancer on the Efficacy of Osimertinib
2026 · Megumi Mizutani, Yoshiya Matsumoto, et al. · Clinical Lung Cancer
Active and Non‐Active Comparators Yield Different Estimates of the Association Between Proton Pump Inhibitor Use and Recorded Mortality During Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer
2026 · Yasutaka Ihara, Naoto Okada, et al. · Pharmacoepidemiology and Drug Safety
PDF
Immunotherapy and overall survival among older patients with advanced non-small cell lung cancer
2026 · Yasutaka Ihara, Naoyuki Nogami, et al. · International Journal of Lung Cancer
Impact of immunotherapy on survival and treatment patterns of patients with extensive-stage small cell lung cancer: a study using a Japanese nationwide database
2026 · Ihara, Yasutaka, Yamamoto, Shoichiro, et al. · Figshare
Anti-programmed Death-ligand 1 Antibody-associated Eosinophilic Granulomatosis with Polyangiitis in Non-small Cell Lung Cancer
2025 · Akira Sugimoto, Hiroyasu Kaneda, et al. · Internal Medicine
PDF
Association between pleurodesis before immunotherapy and pneumonitis in non-small cell lung cancer
2025 · Megumi Mizutani, Yasutaka Ihara, et al. · Respiratory Investigation
PDF
Differences in Lung Cancer-related Clinical Practice and Basic Research Background between Japan and China: A Narrative Review
2025 · Lan Wang, Yiyan Miao, et al. · Internal Medicine
PDF
Application and Advancement of Bronchoscopic Biopsy Techniques for the Diagnosis of Pulmonary Nodules
2024 · Lan Wang, Yiyan Miao, et al. · Respiratory Endoscopy
Establishing a new human lung squamous cell carcinoma cell line, OMUL ‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 1
2024 · Hiroaki Nagamine, Masakazu Yashiro, et al. · Thoracic Cancer
PDF
Abstract 3635: Insulin-like growth factor receptor predicts poor prognosis in early-stage non-small cell lung cancer
2024 · Hiroaki nagamine, Masakazu Yashiro, et al. · Cancer Research
Abstract 2519: Alteration of tumor immune microenvironment after recurrence and its impact on the efficacy of anti-PD-1 antibody in resected non-small cell lung cancer patients
2024 · Yoshiya Matsumoto, Tetsuya Watanabe, et al. · Cancer Research
[effectiveness of Add-on Sublingual Immunotherapy for the Treatment of Japanese Cedar Pollinosis-associated Allergic Asthma Is It Possible to Reduce the Dose of Inhaled Corticosteroid by Adding Sublingual Immunotherapy?]
2021 · Kyohei Morita, Toshitaka Morishima, et al. · Arerugī (Allergy)
Works count: 21
Citation count: 35
H-index: 3
I10-index: 1
Year
Topic
Type